• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

patient data

Re: patient data

Influenza Pandemic (H1N1) 2009, Vietnam, Patient Data (from ProMedMail.org, edited)

INFLUENZA PANDEMIC (H1N1) 2009 - VIET NAM: PATIENT DATA

A ProMED-mail post
<http: www.promedmail.org=""> ProMED-mail is a program of the International Society for Infectious Diseases <http: www.isid.org="">
Date: Wed 8 Jul 2009
From: Rogier van Doorn


</http:></http:><http: www.promedmail.org=""><http: www.isid.org=""><hrogier@gmail.com>In the Hospital for Tropical Diseases in Ho Chi Minh City, Viet Nam, patients with flu symptoms and a positive RT-PCR [real time polymerase chain reaction] result for pandemic (H1N1) 2009 virus infection with the CDC assay (specific A(H1N1)v primers/probe) are hospitalized and treated with oseltamivir (75mg bd) until RT-PCR results are negative. </hrogier@gmail.com></http:></http:>
<http: www.promedmail.org=""><http: www.isid.org=""><hrogier@gmail.com></hrogier@gmail.com></http:></http:>
<http: www.promedmail.org=""><http: www.isid.org=""><hrogier@gmail.com>
We collected clinical data, haematology and biochemistry, and daily virological data (nose and throat swabs) from the 1st 44 pandemic (H1N1) 2009 RT-PCR positive patients in Viet Nam hospitalized between 29 May and 26 June 2009.

The average age of the patients was 28.6 years
(3-62), 19 female and 25 male.

5 patients contracted flu while in Viet Nam but with a clear epidemiological link to someone with "imported" pandemic (H1N1) 2009, 39 cases were thought to be directly imported (14 US, 18 Australia, 2 Canada, 2 Thailand, 1 Japan, 1 China, and 1 Singapore).

Fever was present in 91 percent (n=40), cough in 55 percent (n=24), runny nose in 20 percent (n=9), sore throat in 27 percent (n=12), and diarrhea in 2 percent (n=1).

Average duration of fever on presentation was 2 days.

After 24 hours 75 percent
(n=33) of patients had a normal temperature.

All patients had a mild illness course.

Viral PCR was positive on day 0 for all patients with an average Ct value of 30.3.

The number of PCR positive patients dropped to 25 after 1 day (average Ct 30.3).

On day 2, 21 patients were positive (average Ct 35.8) and on day 3 and 4, 8 patients were still PCR positive (average Ct 37.0 and 37.2).

No patients were positive on day 5, 6 and 7.

These data suggest that patients treated with oseltamivir have a favourable clinical and virological response and are not shedding viral RNA after 5 days of treatment.

In comparison, Whitley et al [Pediatr Infect Dis J 2001 20:127] found 55 percent (n=51/93) culture positive patients in oseltamivir treated children with non-severe influenza on day 4.

There have been a few anecdotal reports from Viet Nam of patients that remained symptomatic and PCR positive for a prolonged period, and one patient in our hospital (not included in this report) had a positive PCR after 18 doses of oseltamivir.

Investigations into the presence of the NA H274Y mutation in [virus isolated from] these patients are ongoing but have so far been negative.

[Byline:
Tran Tinh Hien
Nguyen Thanh Truong
Nguyen van Vinh Chau
Tran Thuy Ngan
Jeremy Farrar
Rogier van Doorn
Hospital for Tropical Diseases Ho Chi Minh City Viet Nam]
--
Rogier van Doorn
Hospital for Tropical Diseases
Wellcome Trust Major Overseas Programme
Oxford University Clinical Research Unit
190 Ben Ham Tu District 5 Ho Chi Minh City Viet Nam <rvandoorn@oucru.org>

[ProMED-mail welcomes the opportunity to make these data available to the general healthcare community. - Mod.CP]
-
</rvandoorn@oucru.org></hrogier@gmail.com></http:></http:>​
<cite cite="http://apex.oracle.com/pls/otn/f?p=2400:1001:236173267148590::NO::F2400_P1001_BACK_PAGE,F2400_P1001_PUB_MAIL_ID:1000,78262">http://apex.oracle.com/pls/otn/f?p=..._BACK_PAGE,F2400_P1001_PUB_MAIL_ID:1000,78262</cite>
 
Back
Top Bottom